ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Anxiety and Stress Disorders
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1677506
Assessment of depression and anxiety in Tunisian patients with chronic diseases: impact on quality of life and medication adherence
Provisionally accepted
- 1psychiatry A department, CHU Hopital Hedi Chaker, Sfax, Tunisia
- 2Department of Family Medicine, Universite de Sfax Faculte de Medecine de Sfax, Sfax, Tunisia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Chronic illness affects patients' quality of life and often leads to underdiagnosed psychological issues, which can impact treatment adherence. This study aimed to assess quality of life in Tunisian patients with chronic diseases, screen for anxiety and depression, and evaluate their effect on medication adherence. Methods: We conducted a cross-sectional study including 170 patients consulting at the National Social Security Fund for chronic conditions, from September to November 2022. Quality of life was assessed using the Short Form 12 Health Survey, anxiety and depression using the Hospital Anxiety and Depression scale, and treatment adherence using the Morisky, Green, and Levine scale. Results: Among the 170 patients included in this study, 116 were women (68.2%), with a female-to-male ratio of 2.14. The mean age was 60 years and 5 months ± 9.85 years. The most common conditions were cardiovascular (71.7%), endocrine (64.7%), and pulmonary diseases (40.5%). The prevalences of depression and anxiety were 51.8% and 47%, respectively. Quality of life was impaired, with mean physical and mental scores of 35.05 ± 9.69 and 44.32 ± 11.13, respectively. Anxiety was more prevalent among women (p<0.001) and individuals under 60 years of age (p=0.009). Depression and anxiety were negatively correlated with quality of life. Depressive symptoms were associated with lower levels of treatment adherence (p=0.049). Conclusion: Anxiety and depression were frequent among patients with chronic diseases and were associated with poorer quality of life and lower treatment adherence. These findings underscore the burden of psychological distress in this population and highlight its detrimental effects on both well-being and disease management.
Keywords: Chronic Disease, Anxiety, Depression, Quality of Life, Treatment Adherence, North Africa
Received: 31 Jul 2025; Accepted: 09 Oct 2025.
Copyright: © 2025 Cherif, Frikha, Abdelkefi, Feki, Guermazi and Masmoudi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Farah Cherif, cherif_cherif@medecinesfax.org
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.